#gene editing

One new approach protects CD4 cells against HIV entry, while another snips out viral genes in infected cells.

The National Institutes of Health awarded grants for HIV cure research to these 10 organizations. One focuses on pediatric populations.

An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

The researcher used CRISPR/Cas9 technology to render a pair of twins resistant to HIV.

This finding from early laboratory research may aid in the quest for cure therapies.

CRISPR gene editing eliminates HIV in mice

This amfAR grant hopes to find out. It’s part of $1.16 million in new funding from ARCHE.

A third of mice treated with gene editing technique plus long-acting antiretrovirals showed no remaining traces of HIV.

A look at HIV-related headlines across the globe

Interfering with this receptor on immune cells could have harmful health consequences.

This finding may eventually make HIV gene therapies more affordable and accessible.

Two gene-editing experts said Jiankui He’s actions were a “gross violation” of Chinese regulations and international standards.

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

In a recent small trial, researchers have been unable to detect viable virus in the tissues of two monkeys that received the treatment.

Researchers think a more efficient means of modifying immune cells to resist the virus could yield a stronger effect.